Back to search

Article

Itaconate delays type 2 diabetes progression by alkylating RIPK3 to inhibit pancreatic β‑cell failure

2026-08-10

Abstract excerpt

<title>Abstract</title> <p>Dysregulated glucose and lipid metabolism drives β-cell failure, a central event in type 2 diabetes (T2D) pathogenesis; however, effective mechanisms to preserve β-cell mass remain elusive. Through comprehensive metabolomic profiling of human serum, we identified itaconate as a novel metabolic biomarker reduced in T2D patients in a disease severity–dependent manner. Genetic ablation of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
597e460d-5a8e-58d3-8801-6b44bd7cf39a
DOI
10.21203/rs.3.rs-10537918/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Itaconate delays type 2 diabetes progression by alkylating RIPK3 to inhibit pancreatic β‑cell failureDOI 10.21203/rs.3.rs-10537918/v1
Select a neighboring publication to make it the new centre.